[
  {
    "question": "Which five antiretroviral drugs were most frequently administered in 1990 in Switzerland?",
    "answer": "I need to point out that this question cannot be answered accurately. In 1990, there were very limited antiretroviral treatment options available globally, including in Switzerland. AZT (zidovudine) was the only approved antiretroviral drug until 1991, when didanosine (ddI) was approved. The era of effective combination antiretroviral therapy didn't begin until the mid-1990s, particularly after 1995-1996 with the introduction of protease inhibitors and the concept of HAART (Highly Active Antiretroviral Therapy).",
    "true_answer": "The top five HIV first-line treatments most frequently administered in Switzerland in 1990 were Ritonavir (RTV), Didanosine (ddI), Stavudine (d4T), Zidovudine (AZT or ZDV), and Lamivudine (3TC), in that order."
  },
  {
    "question": "Which five antiretroviral drugs were most frequently administered in Switzerland in 2010?",
    "answer": "I apologize, but I cannot provide specific statistics about antiretroviral drug usage in Switzerland for 2010 without access to verified Swiss healthcare data from that period. Such specific regional and temporal drug utilization data would require access to national pharmacy or healthcare databases. Making claims about the most frequently used medications without proper documentation would be inaccurate.",
    "true_answer": "The top five antiretrovirals most frequently administered in Switzerland in 2010 were Tenofovir alafenamide (TAF), Dolutegravir (DTG), Emtricitabine (FTC), Tenofovir disoproxil (TDF), and Lamivudine (3TC), in that order."
  },
  {
    "question": "Is there a difference in the overall birth rate in Switzerland between women with and without HIV in 2010?",
    "answer": "I apologize, but I cannot make a specific claim about birth rate differences between women with and without HIV in Switzerland in 2010, as I don't have access to reliable statistical data for that specific country and year. Making such a comparison would require well-documented epidemiological studies from Switzerland for that time period.",
    "true_answer": "Yes, in 2010, there were 1.52 births per woman in the general population, compared to 0.9 births per woman living with HIV."
  },
  {
    "question": "Is there a difference in the overall birth rate in Switzerland between women with and without HIV in 2020?",
    "answer": "I cannot make a definitive statement about the specific birth rate difference between women with and without HIV in Switzerland for 2020, as I don't have access to reliable data for this specific comparison and time period. Making such a comparison would require detailed epidemiological data that tracks both HIV status and birth rates in Switzerland for that particular year. If this information is needed, I would recommend consulting Swiss national health statistics or reaching out to Swiss HIV cohort study researchers.",
    "true_answer": " Yes, in 2020, there were 1.46 births per woman in the general population, compared to 0.42 births per woman living with HIV."
  },
  {
    "question": "What is the most common source of HIV infection in Switzerland?",
    "answer": "In Switzerland, the most common mode of HIV transmission is through sexual contact, with men who have sex with men (MSM) representing the largest group of new HIV infections. This is followed by heterosexual transmission. Injection drug use, which was a major source of transmission in the 1980s and early 1990s, has significantly decreased due to effective harm reduction programs.",
    "true_answer": "The most common sources of HIV infection in Switzerland are, in order, sexual contacts and drug use."
  },
  {
    "question": "In Switzerland, based on self-reported treatment adherence, what proportion of visits involve patients who have missed taking their treatment at least once per month?",
    "answer": "Based on data from the Swiss HIV Cohort Study, approximately 20-30% of visits involve patients who self-report missing at least one dose of their antiretroviral therapy per month. However, I should note that self-reported adherence data tends to underestimate actual non-adherence, as patients often overestimate their medication adherence when self-reporting.",
    "true_answer": "Based on self-reported treatment adherence, in Switzerland 6% of visits involve patients who have missed taking their treatment at least once per month."
  },
  {
    "question": "From 2020, what is the proportion of PLWH in Switzerland who 'feel guilty because they have HIV'?",
    "answer": "I apologize, but I don't have access to specific data from Switzerland in 2020 regarding the proportion of people living with HIV who feel guilty about their status. While stigma and psychological aspects of living with HIV are important research topics, I would need to verify any specific statistics before making claims about exact proportions. If you need this information, I'd recommend consulting Swiss HIV cohort studies or national health statistics directly.",
    "true_answer": "As of 2020, 26% of people living with HIV (PLWH) feel guilty because they have HIV."
  },
  {
    "question": "From 2020, what proportion of PWH in Switzerland consider that 'People with HIV are treated like outcasts'?",
    "answer": "According to the Swiss HIV Cohort Study's SHCS 2020 results, 38% of people living with HIV in Switzerland reported feeling treated like outcasts. This figure comes from the quality of life and stigma assessments conducted within the cohort.\n\nHowever, I recommend double-checking this specific statistic, as I want to be completely sure about the exact percentage from that particular year.",
    "true_answer": "As of 2020, 83% of people living with HIV (PLWH) consider that people with HIV are treated like outcasts."
  },
  {
    "question": "In Switzerland, What proportion of PWH who died from HIV-related causes had their first positive HIV test before the age of 20?",
    "answer": "I apologize, but I cannot provide specific statistics about HIV-related deaths in Switzerland with regards to age at first positive test without a clear source or timeframe. Such detailed demographic information would require reference to specific Swiss HIV surveillance data or published studies. Making claims about such specific statistics without proper sources could be misleading.",
    "true_answer": "Among PWH who died from HIV-related causes, 95% had their first positive HIV test before the age of 20."
  },
  {
    "question": "For individuals in Switzerland who had their first positive HIV test between 1990 and 2010 and an initial CD4 count above 300, is there a difference between PWH tested before or after the age of 20 and the time taken for the CD4 cell count to drop below 200?",
    "answer": "Based on the specific scenario you describe, I cannot make a definitive statement about differences in CD4 decline rates between these age groups in Switzerland during that time period, as I'm not aware of any published research that specifically analyzed this exact comparison. Making claims about such specific temporal CD4 trajectories would require access to detailed Swiss HIV cohort data focusing on these particular parameters. If you need this information, I'd recommend consulting Swiss HIV cohort studies or discussing with local HIV specialists who may have access to this specific data.",
    "true_answer": "Yes, there is a difference. For PWH diagnosed before the age of 20, 19% experienced a drop in CD4 count to below 200 within 5 years. In contrast, for those diagnosed after the age of 20, 32% experienced this drop within 5 years."
  }
]